Compound used as dual inhibitor for RAAS (rennin angiotensin aldosterone system)

A technology of compounds and drugs, applied in the field of compounds as dual inhibitors of RAAS system
CN104496971AActive Publication Date: 2015-04-08ZHEJIANG YONGTAI TECH CO LTD

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
ZHEJIANG YONGTAI TECH CO LTD
Publication Date
2015-04-08

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a compound used as a dual inhibitor for RAAS (rennin angiotensin aldosterone system) and particularly relates to a compound shown in formula (I), a stereisomer thereof or a pharmaceutically acceptable salt thereof. The compound can be used for treating and blocking RAS-associated diseases such as hypertension and heart disease, can be used for preventing or treating hypertension, congestive heart failure, pulmonary hypertension, renal insufficiency, renal ischemia, kidney failure, renal fibrosis, cardiac insufficiency, cardiac hypertrophy, cardiac fibrosis, myocardial ischemia, cardiomyopathy, glomerulonephritis, renal colic, complications such as nephropathy caused by diabetes, vasculopathy, vasculopathy, glaucoma, intraocular pressure elevation, atherosis, restenosis after revascularization, complications after blood vessel or cardiac operation, erectile dysfunction, hyperaldosteronism, lung fibrosis, scleroderma, anxiety, cognitive disorder, complications caused by immunosuppressor treatment as well as other known diseases associated with the rennin angiotensin aldosterone system.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a compound as a dual inhibitor of renin-angiotensin-aldosterone (RAAS) system, which can be used for treating diseases related to the RAS system, including hypertension, heart disease and the like. Background technique

[0002] The renin-angiotensin-aldosterone system (RAAS) is a complex and highly efficient system necessary for the regulation of blood flow, electrolyte balance, and arterial blood pressure. The two main parts of this system are renin and angiotensin transferase. Renin is an aspartyl protease that converts angiotensinogen produced in the liver into angiotensin I, and angiotensin I generates blood vessels under the action of angiotensin I converting enzyme (ACE) Tensin II is finally converted into angiotensin III that can promote aldosterone secretion and inactivated. Angiotensin Ⅱ is a powerful peptide vasoconstrictor that can promote the release of norepinephrine from nerve endings, and can also activate prot...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More